Creso Pharma’s (ASX:CPH) goal is to become the world’s most trusted supplier of cannabis and hemp derived products. The company’s experienced pharmaceutical leadership team have an unparalleled track record of success commercialising a wide range of pharmaceutical and therapeutic solutions.
CPH Kick Start African Launch - $300k Order Values Confirmed
Dec 9, 2019
Creso Pharma (ASX:CPH | FRA:1X8) has announced that through Pharma Dynamics, Creso’s partner in the African region, initial orders worth approximately A$300,000 for the cannaQIX® product range have been made.
Canada Legalises Cannabis as CPH Moves Front and Centre With a 100% Owned Canadian Growing Facility
Oct 18, 2018
CPH Gets Green Light to Distribute its Innovative CBD Based Nutraceutical Products in the UK
Jan 18, 2018
CPH Seal Swiss Pharma Deal: Setting the Cornerstone for Global Commercialisation of cannaQIX
Dec 4, 2017
CPH to Acquire Canadian Cannabis Grower and Strengthen Position in Multi-Billion Dollar Market
Jul 27, 2017
First Cannabis Revenues in Sight for CPH
Nov 7, 2016